Decrease in the Usage of Digitalis Glycosides
The development of potent medications to unload the left ventricle and the availability of very effective diuretics means the use of digitalis has been de-emphasized despite its long-standing position as a mainstay in the management of CHF and for rate control in AF. Nevertheless, when used properly, and that is the key, digitalis still has a place in clinical cardiology. For those with less experience, appropriate use of digitalis may be problematic, and the secret to continuing the proper clinical use of the foxglove derivatives appears to be the dedicated practitioner, possibly led and exemplified by the medical CHF specialist.
Am J Cardiovasc Drugs. 2018;18(6):427-440. © 2018 Adis Springer International Publishing AG